Iram, Mohammad Taha O.

HRN: 21-59-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2022
CEFUROXIME 750MG (VIAL)
07/17/2022
07/23/2022
IV
360mg
Q8Hrs
AGE With Severe Dehydration
Waiting Final Action 
07/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/17/2022
07/23/2022
IV
180mg
Q8Hrs
AGE With Severe Dehydration
Waiting Final Action 
07/19/2022
CEFTRIAXONE 1G (VIAL)
07/19/2022
07/25/2022
IVT
435mg
Q12
Infectious Diarrhea
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: